Clear, engaging, and practical updates on clinical psychiatry.

Earn CME for listening to the podcast with a multimedia subscription. Listen for free here or using Apple Podcasts, Android, or Stitcher.

Previous Post
Next Post

What You Need to Know About Kloxxado

Podcast, Volume , Number ,

Print Friendly, PDF & Email


On April 30th of this year, the FDA approved Kloxxado, a naloxone nasal spray that contains 8mg of naloxone per dose, which is twice as much as the most common formulation: Narcan. But what distinguishes Kloxxado distinguishes from the many other ways that naloxone is delivered and why was it developed in the first place?

Published On: 8/16/2021

Duration: 21 minutes, 01 seconds

Articles Referenced:A New High-Dose Naloxone: Life Saver or Punishment?,” The Carlat Addiction Treatment Report,” July/August 2021;

Naloxone Prescribing,” The Carlat Addiction Treatment Report,” July/August 2021

Got feedback? Take the podcast survey.


Leave A Comment